The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious approach when it comes to buying other companies, which are expensively priced.

$80,000 of MERCK KGAA DARMSTADT GERMANY lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Issues related to chemical ...

German pharmaceutical and chemical company Merck is investing more than €300 million ($320 million) in a new research centre at its headquarters in the western German city of Darmstadt south of ...

Germany’s Merck KGaA has reached a deal with Chinese pharma company Jiangsu Hengrui that covers a pair of cancer drugs, including a ‘next-generation’ PARP inhibitor and an antibody-drug ...

Merck has just released a cyber-to-physical platform that uses crypto anchor technology and other tools to help crush the counterfeit product market.

Dr. Michael Har-Noy, Founder and Chief Medical Officer of Mirror Biologics stated: “We are pleased to enter into this ...

the philanthropic arm of Merck KGaA Germany, conducted the 11 th Edition of their annual conference, “Merck Foundation Africa Asia Luminary”, under the patronage of The President of Tanzania ...

BURLINGTON, Mass.--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced that the Life Science business of Merck KGaA, Darmstadt ...

This annual award with a remuneration of €30,000 was jointly established by Merck and the University of Darmstadt, Germany, in 1992. It seeks to recognize globally renowned scientists who have ...